Dr. Danielle R. Armas

Family Medicine
Mayo Clinic Family Medicine Thunderbird
13737 N 92nd St, 
Scottsdale, AZ 
Mayo Clinic Family Medicine Thunderbird
13737 N 92nd St, 
Scottsdale, AZ 

Overview

Danielle Armas is a primary care provider, practicing in Family Medicine in Scottsdale, Arizona.

She is actively involved in clinical research, co-authoring 13 peer reviewed articles and participating in 7 clinical trials.

Specialties

Family Medicine

Licenses

Family Medicine in AZ

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Mayo Clinic Family Medicine Thunderbird
13737 N 92nd St, Scottsdale, AZ 85260

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Positive-Controlled, Four-Way Crossover Study to Investigate the Effect of BL-8040 (Motixafortide) on the QTc Interval in Healthy Subjects
A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Positive-Controlled, Four-Way Crossover Study to Investigate the Effect of BL-8040 (Motixafortide) on the QTc Interval in Healthy Subjects
Enrollment Status: Completed
Publish Date: March 21, 2025
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-label Trial to Evaluate the Pharmacokinetics of CVL-231 Following Single Oral Administration of Modified- and Immediate-release Formulations Under Fasted and Fed Conditions in Healthy Participants
A Phase 1, Open-label Trial to Evaluate the Pharmacokinetics of CVL-231 Following Single Oral Administration of Modified- and Immediate-release Formulations Under Fasted and Fed Conditions in Healthy Participants
Enrollment Status: Completed
Publish Date: April 27, 2022
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open Label, Randomized, Single-Dose, Replicate Crossover Study to Determine the Bioavailability of the Tablet Formulation Relative to the Capsule Formulation of TAK-906 and the Effect of Food on the Pharmacokinetics of the Tablet Formulation in Healthy Subjects
A Phase 1, Open Label, Randomized, Single-Dose, Replicate Crossover Study to Determine the Bioavailability of the Tablet Formulation Relative to the Capsule Formulation of TAK-906 and the Effect of Food on the Pharmacokinetics of the Tablet Formulation in Healthy Subjects
Enrollment Status: Withdrawn
Publish Date: March 24, 2022
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-Label, Randomized, Crossover Study to Evaluate the Relative Bioavailability of Different TAK-994 Formulations and the Effect of Food on These Formulations in Healthy Adult Subjects
A Phase 1, Open-Label, Randomized, Crossover Study to Evaluate the Relative Bioavailability of Different TAK-994 Formulations and the Effect of Food on These Formulations in Healthy Adult Subjects
Enrollment Status: Completed
Publish Date: April 22, 2021
Intervention Type: Drug
Study Phase: Phase 1
A Single-Center, Randomized, Double-Blind, Placebo-Controlled Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of ABP-671 in Healthy Volunteers in the United States
A Single-Center, Randomized, Double-Blind, Placebo-Controlled Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of ABP-671 in Healthy Volunteers in the United States
Enrollment Status: Completed
Publish Date: July 29, 2020
Intervention Type: Drug, Other
Study Phase: Phase 1
A Phase 1, Randomized, Double-Blind, Single and Multiple Ascending Dose Trial of the Safety, Tolerability and Pharmacokinetics of NPT520-34 in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Single and Multiple Ascending Dose Trial of the Safety, Tolerability and Pharmacokinetics of NPT520-34 in Healthy Subjects
Enrollment Status: Completed
Publish Date: January 13, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Randomized Double-Blind Study to Assess the Skin Irritation and Sensitization Potential of Once-Weekly Corplex™ Donepezil Transdermal Delivery System
A Randomized Double-Blind Study to Assess the Skin Irritation and Sensitization Potential of Once-Weekly Corplex™ Donepezil Transdermal Delivery System
Enrollment Status: Completed
Publish Date: September 14, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 6 Less Clinical Trials

13 Total Publications

Assessment of QT Interval Prolongation Using Concentration-QT Modeling for Iptacopan, an Oral Complement Factor B Inhibitor, in Healthy Individuals.
Assessment of QT Interval Prolongation Using Concentration-QT Modeling for Iptacopan, an Oral Complement Factor B Inhibitor, in Healthy Individuals.
Journal: Clinical and translational science
Published: March 25, 2025
Similar Doctors
Expertise in
142
conditions
Dr. Elise R. Donnelly
Family Medicine
Expertise in
142
conditions
Dr. Elise R. Donnelly
Family Medicine
Before you request

Honorhealh Medical Group TPK

20745 N Scottsdale Rd Ste 100, 
Scottsdale, AZ 
 (5.1 miles away)
480-882-7500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Elise Donnelly is a primary care provider, practicing in Family Medicine in Scottsdale, Arizona. Dr. Donnelly is highly rated in 142 conditions, according to our data. Her clinical expertise encompasses Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and High Cholesterol. Dr. Donnelly is currently accepting new patients.

Expertise in
4
conditions
Dr. Noralane M. Lindor
Family Medicine
Expertise in
4
conditions
Dr. Noralane M. Lindor
Family Medicine

Mayo Clinic Building Scottsdale

13400 E Shea Blvd, 
Scottsdale, AZ 
 (5.3 miles away)
480-301-6817
Languages Spoken:
English

Noralane Lindor is a primary care provider, practicing in Family Medicine in Scottsdale, Arizona. Dr. Lindor is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Ruvalcaba Syndrome, Colonoscopy, and Endoscopy.

Expertise in
7
conditions
Dr. James F. Burke
Family Medicine
Expertise in
7
conditions
Dr. James F. Burke
Family Medicine

HonorHealth Scottsdale Shea Medical Center

9003 E Shea Blvd, 
Scottsdale, AZ 
 (2.1 miles away)
480-323-3000
Languages Spoken:
English

James Burke is a primary care provider, practicing in Family Medicine in Scottsdale, Arizona. Dr. Burke is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Stroke, Status Epilepticus, Epilepsy, Noma, and Thrombectomy.

Frequently Asked Questions about Dr. Danielle R. Armas

How do I make an appointment with Dr. Danielle R. Armas?

You can book an appointment with Dr. Danielle R. Armas by calling their office at 480-301-8000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Armas's expertise for a condition
ConditionClose

We do not have enough information to identify the Areas of Expertise for this provider.

Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile